GO:0051146 striated muscle cell differentiation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051146 (striated muscle cell differentiation) describes the developmental process by which a precursor cell acquires the specialized structural and functional features of a striated muscle cell, including myoblast commitment, myocyte fusion and sarcomere assembly.
• The process is controlled by sequential transcription-factor cascades (MYOD1, MYF5, MYF6/MRF4, MYOG, MYH2) and by chromatin reorganization in muscle stem cells.
• Extracellular matrix composition, including native collagen VI, actively delays early muscle stem cell differentiation, showing that the niche is a timing regulator of GO:0051146.
• Signaling inputs such as Wnt/β-catenin and RNF138-dependent regulation modulate the efficiency of skeletal muscle differentiation.
• Human pluripotent stem cells can be directed in vitro to form muscle fibers and satellite-like cells, providing a tractable model for studying GO:0051146.
• Small molecules such as catechin and uremic toxins such as indoxyl sulfate can respectively promote or inhibit muscle cell differentiation, linking GO:0051146 to nutrition and chronic kidney disease.
Description
GO:0051146, striated muscle cell differentiation, is the biological process through which precursor cells acquire the morphological, biochemical and functional properties of striated muscle cells, the contractile cells of skeletal and cardiac muscle. This process is central to muscle development, postnatal growth and regeneration, and its dysregulation underlies a broad spectrum of acquired and inherited muscle disorders. Because striated muscle cell differentiation integrates transcriptional programs, chromatin remodeling, cell-fusion events and extracellular matrix cues, it is a paradigm for studying how a single cell fate is progressively specified. Mechanistically, striated muscle cell differentiation proceeds from muscle stem cell activation through myoblast proliferation, cell-cycle exit, myocyte fusion and sarcomere assembly, with each stage marked by defined transcription factors and structural proteins. The transcription factor network includes MYOD1, MYF5, MYF6/MRF4 and MYOG, while terminal differentiation is reflected by expression of contractile proteins such as MYH2. Chromatin organization in muscle stem cells is now recognized as a key determinant of whether cells remain quiescent or commit to differentiation. For researchers, GO:0051146 is both a readout and a target: it can be monitored by marker expression, fusion indices and sarcomere imaging, and it can be perturbed genetically or pharmacologically. This article summarizes the authoritative ontology annotation, the core stages of the process, the genes and regulatory inputs involved, and the experimental and CRISPR-based methods used to study it.
striated muscle cell differentiation At A Glance
| GO ID | GO:0051146 |
|---|---|
| GO term | striated muscle cell differentiation |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Specification and maturation of striated muscle cells, including myoblast commitment, fusion and sarcomere assembly |
| Key transcription factors | MYOD1, MYF5, MYF6/MRF4, MYOG |
| Key structural readout | MYH2 and other sarcomeric proteins |
| Niche regulators | Native collagen VI and extracellular matrix composition |
| Representative in vitro model | Human pluripotent stem cell-derived muscle fibers and satellite-like cells |
What Is GO:0051146?
In our own words, GO:0051146 (striated muscle cell differentiation) is the developmental process in which a cell becomes a striated muscle cell, acquiring the specialized contractile apparatus and gene-expression program characteristic of skeletal or cardiac muscle. It encompasses the commitment of precursor cells, their morphological maturation, and the assembly of sarcomeric structures that define the striated muscle phenotype.
Why Is striated muscle cell differentiation Important in Cell Biology?
Striated muscle cell differentiation is fundamental to the formation, maintenance and regeneration of skeletal and cardiac muscle, and its disruption is directly implicated in muscle wasting, chronic kidney disease-associated myopathy and inherited muscle disorders. Because the process is experimentally tractable in vitro and in vivo, it serves as a model for understanding how transcription-factor cascades, chromatin state and extracellular cues converge on a single differentiation outcome.
• Defines the core developmental program that generates contractile skeletal and cardiac muscle cells.
• Provides a mechanistic framework for muscle regeneration after injury, since muscle stem cell activation precedes differentiation.
• Is directly inhibited by uremic toxins such as indoxyl sulfate, linking GO:0051146 to chronic kidney disease-associated muscle dysfunction.
• Is modulated by extracellular matrix proteins such as native collagen VI, which delays early muscle stem cell differentiation.
• Is regulated by signaling pathways including Wnt/β-catenin through RNF138, offering druggable nodes.
• Can be promoted by dietary compounds such as catechin, connecting the process to nutrition and muscle health.
• Is recapitulated in human pluripotent stem cell models, enabling disease modeling and drug screening.
• Serves as a paradigm for studying chromatin reorganization during stem cell fate transitions.
• Provides biomarkers such as MYH2 and MYF6/MRF4 for monitoring differentiation status.
• Underpins therapeutic strategies for muscle degenerative conditions and regenerative medicine.
What Happens During striated muscle cell differentiation?
Muscle stem cell activation and chromatin priming
In simple terms: Before a muscle cell can specialize, its parent stem cell must be awakened and its DNA must be opened up in the right places.
Striated muscle cell differentiation begins with the activation of muscle stem cells, a transition that depends on the chromatin organization of these cells and on regulators such as TLE4 that control quiescence and differentiation. Chromatin reorganization in muscle stem cells is now recognized as a key determinant of whether cells remain quiescent or commit to the differentiation program. This priming step sets the stage for subsequent transcription-factor-driven differentiation.
Myoblast commitment and transcription-factor cascade
In simple terms: Once activated, precursor cells switch on a series of master regulator proteins that tell them to become muscle.
Committed myoblasts activate a transcription-factor cascade that includes MYOD1, MYF5, MYF6/MRF4 and MYOG. Perturbation of this cascade, for example by indoxyl sulfate, downregulates MYF6/MRF4 and MYH2 and inhibits muscle cell differentiation, demonstrating the centrality of these factors to GO:0051146. RNF138 further regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway, linking extracellular signals to the transcriptional program.
Myocyte fusion and myotube formation
In simple terms: Individual muscle precursor cells stick together and merge into longer, multinucleated tubes that will become muscle fibers.
After commitment, myocytes exit the cell cycle and fuse to form multinucleated myotubes, a hallmark of striated muscle cell differentiation. Ninjurin1 regulates striated muscle growth and differentiation, and its loss affects the growth and differentiation of striated muscle, indicating a role in this fusion and growth phase. Human pluripotent stem cell protocols generate muscle fibers and satellite-like cells in vitro, capturing this fusion step in a controlled setting.
Sarcomere assembly and terminal maturation
In simple terms: The fused muscle cells build the internal contractile machinery that lets them shorten and generate force.
Terminal differentiation involves assembly of sarcomeres and expression of contractile proteins such as MYH2. Downregulation of MYH2 accompanies inhibition of muscle cell differentiation by indoxyl sulfate, making MYH2 a useful terminal marker. Native collagen VI delays early muscle stem cell differentiation, showing that the extracellular environment can modulate the timing of sarcomere maturation.
Metabolic and nutritional modulation of differentiation
In simple terms: What cells are exposed to, from nutrients to toxins, can speed up or slow down their decision to become muscle.
Catechin plays a role in skeletal muscle cell differentiation, indicating that dietary polyphenols can modulate this process. Conversely, the uremic toxin indoxyl sulfate inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation, providing a mechanistic link between chronic kidney disease and impaired muscle differentiation. Together these findings show that GO:0051146 is responsive to both nutritional and pathological metabolic cues.
Key Genes Involved in GO:0051146 striated muscle cell differentiation
The following genes and proteins are experimentally implicated in striated muscle cell differentiation (GO:0051146) in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOD1 | Master myogenic transcription factor in the commitment cascade | Marker and perturbation target for myoblast commitment |
| MYF5 | Myogenic regulatory factor contributing to myoblast specification | Used to assess early differentiation states |
| MYF6/MRF4 | Myogenic factor whose downregulation inhibits differentiation | Readout for differentiation inhibition by uremic toxins |
| MYOG | Myogenin, promotes terminal differentiation | Marker of terminal myocyte differentiation |
| MYH2 | Sarcomeric myosin heavy chain expressed in maturing muscle cells | Terminal differentiation marker |
| RNF138 | Regulates skeletal muscle differentiation via Wnt/β-catenin | Candidate for signaling-focused perturbation |
| TLE4 | Regulates muscle stem cell quiescence and skeletal muscle differentiation | Target for stem cell fate studies |
| NINJ1 (Ninjurin1) | Regulates striated muscle growth and differentiation | Model for growth and differentiation coupling |
| COL6A (collagen VI) | Native collagen VI delays early muscle stem cell differentiation | Niche factor for timing experiments |
| TLE family corepressors | Contribute to transcriptional repression in stem cells | Epigenetic regulation studies |
| Wnt/β-catenin pathway components | Signal upstream of RNF138 to regulate differentiation | Pathway-level perturbation |
| Chromatin remodeling factors | Control muscle stem cell chromatin organization | Epigenomic studies of differentiation |
| Catechin-responsive targets | Mediate nutritional modulation of differentiation | Nutraceutical intervention studies |
| Satellite-like cell markers | Identify stem-like progeny in vitro | Stem cell derivation and characterization |
| Sarcomeric structural proteins | Build the contractile apparatus | Imaging and functional assays |
| Indoxyl sulfate-responsive genes | Mediate toxin-induced inhibition of differentiation | CKD-related muscle dysfunction models |
How Is striated muscle cell differentiation Regulated?
Striated muscle cell differentiation is regulated at multiple levels. Extracellularly, native collagen VI delays early muscle stem cell differentiation, demonstrating niche control of timing. Intracellularly, RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway, connecting a ubiquitin-related factor to a canonical developmental pathway. Transcriptionally, the MYOD1/MYF5/MYF6/MYOG cascade governs progression, and its downregulation by indoxyl sulfate inhibits differentiation. Epigenetically, chromatin organization in muscle stem cells determines the competence to differentiate, and TLE4 controls the balance between quiescence and differentiation. Nutritionally, catechin modulates skeletal muscle cell differentiation, indicating that small molecules can influence this regulatory network.
striated muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYF6/MRF4 | Chronic kidney disease-associated inhibition of muscle differentiation | Indoxyl sulfate-treated myoblast differentiation assay |
| MYH2 | Terminal differentiation marker lost in toxin-induced inhibition | MYH2 reporter or immunofluorescence in myotubes |
| TLE4 | Muscle stem cell quiescence and differentiation imbalance | TLE4 knockout muscle stem cell model |
| NINJ1 | Striated muscle growth and differentiation defects | Ninjurin1 loss-of-function mouse or cell model |
| COL6A | Extracellular matrix modulation of early differentiation | Collagen VI-coated or knockout differentiation cultures |
Chronic kidney disease-associated muscle dysfunction
Indoxyl sulfate, a uremic toxin, inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation, providing a mechanistic explanation for impaired muscle differentiation in chronic kidney disease. This links GO:0051146 directly to a common acquired muscle phenotype in renal disease.
Muscle wasting and impaired regeneration
Because muscle stem cell quiescence and differentiation are controlled by factors such as TLE4 and by chromatin organization, disruption of these regulators can impair regeneration and contribute to muscle wasting. Native collagen VI delays early differentiation, suggesting that altered matrix composition may also perturb regenerative timing.
Inherited and structural muscle disorders
Terminal differentiation depends on sarcomeric proteins such as MYH2, and Ninjurin1 regulates striated muscle growth and differentiation, so defects in these programs are relevant to structural muscle disorders. Human pluripotent stem cell-derived muscle fibers and satellite-like cells provide a platform to model such defects in vitro.
Metabolic and nutritional influences on muscle
Catechin influences skeletal muscle cell differentiation, indicating that dietary factors can modulate the process and may be relevant to muscle health interventions. Conversely, uremic toxins suppress differentiation, illustrating how metabolic status shapes GO:0051146.
From striated muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is RNF138 required for skeletal muscle differentiation? | RNF138 knockout myoblast line |
| Does loss of TLE4 alter quiescence versus differentiation? | TLE4 knockout muscle stem cells |
| How does Ninjurin1 loss affect striated muscle growth? | Ninjurin1 knockout mouse or cell model |
| Can a disease-associated point mutation impair myogenic factor function? | Point-mutation knock-in of MYF6/MRF4 or MYOD1 |
| Does tagging a sarcomeric protein alter its localization? | Endogenous MYH2 knock-in with a fluorescent tag |
| Does overexpression of a myogenic factor accelerate differentiation? | MYOD1 or MYOG overexpression in myoblasts |
| Can human pluripotent stem cells model differentiation? | Directed differentiation to muscle fibers and satellite-like cells |
How to Study the striated muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RT-qPCR | Expression of MYF6/MRF4, MYOG, MYH2 | Monitoring differentiation status |
| Immunofluorescence | Myotube formation and sarcomere proteins | Visualizing fusion and maturation |
| Chromatin accessibility assays | Muscle stem cell chromatin organization | Epigenomic studies of quiescence |
| Pluripotent stem cell differentiation | Generation of muscle fibers and satellite-like cells | Disease modeling and drug screening |
| Pathway inhibition/activation | Wnt/β-catenin and RNF138-dependent signaling | Dissecting regulatory inputs |
| Extracellular matrix coating | Effect of native collagen VI on differentiation timing | Niche factor experiments |
| Small-molecule treatment | Catechin or indoxyl sulfate effects | Nutritional and toxicological modulation |
Transcript and marker analysis
Quantitative expression of myogenic transcription factors such as MYF6/MRF4 and MYOG, and of terminal markers such as MYH2, is used to monitor striated muscle cell differentiation. These readouts are sensitive to inhibitors such as indoxyl sulfate and to modulators such as catechin.
Chromatin and epigenomic profiling
Because chromatin organization in muscle stem cells influences differentiation, epigenomic methods are used to map accessibility and repressive complexes involving TLE4. Such approaches reveal how stem cell quiescence is maintained or released.
Stem cell differentiation and imaging
Human pluripotent stem cells can be directed to generate muscle fibers and satellite-like cells, enabling imaging of fusion and sarcomere formation. These cultures allow direct visualization of the morphological transitions that define GO:0051146.
Pathway and perturbation studies
Signaling-focused experiments, such as those examining RNF138 and Wnt/β-catenin, test how specific pathways control differentiation efficiency. Extracellular matrix manipulations with native collagen VI test niche timing effects.
How CRISPR Can Be Used to Study GO:0051146 striated muscle cell differentiation
Knockout
CRISPR knockout of candidate regulators such as RNF138, TLE4 or NINJ1 can test whether they are required for striated muscle cell differentiation. Loss-of-function models are particularly informative for genes whose downregulation inhibits differentiation, such as MYF6/MRF4.
Point Mutation
Point-mutation knock-in can model disease-associated variants in myogenic factors or sarcomeric proteins and assess their impact on differentiation. Such models help distinguish pathogenic variants from benign polymorphisms in GO:0051146-related genes.
Knock-in
Tagged knock-in of endogenous loci, for example MYH2 with a fluorescent reporter, enables live tracking of terminal differentiation and sarcomere assembly. Knock-in of reporter cassettes at myogenic loci can also provide sensitive differentiation readouts.
Overexpression
Overexpression of myogenic transcription factors such as MYOD1 or MYOG can drive or accelerate differentiation, while overexpression of inhibitory factors can block it. These gain-of-function models complement knockout studies to establish causality in GO:0051146.
How EDITGENE Supports striated muscle cell differentiation Research
Researchers studying striated muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in myoblast commitment, fusion or sarcomere assembly, and which regulatory pathway it acts through. EDITGENE provides the full spectrum of CRISPR cell-model services to answer these questions with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for striated muscle cell differentiation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CHUK Knockout HEK293 Cell Line | EDJ-KQ556 | Human | 1147 | Details Get a Quote |
| CASP3 Knockout HEK293 Cell Line | EDJ-KQ632 | Human | 836 | Details Get a Quote |
| CASP7 Knockout HEK293 Cell Line | EDJ-KQ1477 | Human | 840 | Details Get a Quote |
| MTLN Knockout HEK293 Cell Line | EDJ-KQ6132 | Human | 205251 | Details Get a Quote |
| POPDC3 Knockout HEK293 Cell Line | EDJ-KQ12091 | Human | 64208 | Details Get a Quote |
| POPDC1 Knockout HEK293 Cell Line | EDJ-KQ12582 | Human | 11149 | Details Get a Quote |
| POPDC2 Knockout HEK293 Cell Line | EDJ-KQ14834 | Human | 64091 | Details Get a Quote |
| CASP3 Knockout HCT 116 Cell Line | EDJ-KQ18053 | Human | 836 | Details Get a Quote |
| CHUK Knockout A-549 Cell Line | EDJ-KQ18927 | Human | 1147 | Details Get a Quote |
| CHUK Knockout HCT 116 Cell Line | EDJ-KQ18928 | Human | 1147 | Details Get a Quote |
| CHUK Knockout HeLa Cell Line | EDJ-KQ18929 | Human | 1147 | Details Get a Quote |
| CASP3 Knockout A-549 Cell Line | EDC07646 | Human | 836 | Details Get a Quote |
| CASP3 Knockout HeLa Cell Line | EDJ-KQ19099 | Human | 836 | Details Get a Quote |
| CASP7 Knockout A-549 Cell Line | EDJ-KQ21057 | Human | 840 | Details Get a Quote |
| CASP7 Knockout HCT 116 Cell Line | EDJ-KQ21058 | Human | 840 | Details Get a Quote |
Frequently Asked Questions About striated muscle cell differentiation
What is GO:0051146 striated muscle cell differentiation?
GO:0051146 is the biological process by which a cell acquires the specialized features of a striated muscle cell, including commitment, fusion and sarcomere assembly.
What genes are involved in striated muscle cell differentiation?
Key genes include MYOD1, MYF5, MYF6/MRF4, MYOG, MYH2, RNF138, TLE4 and NINJ1, among others.
How is striated muscle cell differentiation regulated?
It is regulated by transcription-factor cascades, Wnt/β-catenin signaling via RNF138, chromatin organization in muscle stem cells, and extracellular matrix cues such as native collagen VI.
Which diseases are linked to impaired striated muscle cell differentiation?
Chronic kidney disease-associated muscle dysfunction, muscle wasting and structural muscle disorders have been linked to impaired differentiation.
What markers are used to measure striated muscle cell differentiation?
MYF6/MRF4, MYOG and MYH2 are commonly used markers, along with myotube formation and sarcomere imaging.
Can human pluripotent stem cells be used to study striated muscle cell differentiation?
Yes, human pluripotent stem cells can be directed to generate muscle fibers and satellite-like cells in vitro.
Does the extracellular matrix affect striated muscle cell differentiation?
Yes, native collagen VI delays early muscle stem cell differentiation, showing that matrix composition regulates timing.
Can nutrition influence striated muscle cell differentiation?
Catechin has been reported to play a role in skeletal muscle cell differentiation, indicating nutritional modulation.
What CRISPR models are used to study striated muscle cell differentiation?
Knockout, point-mutation, knock-in and overexpression models are used to test candidate genes such as RNF138, TLE4 and MYH2.
Why is striated muscle cell differentiation important for regenerative medicine?
Because it underlies muscle formation and repair, understanding GO:0051146 supports strategies for muscle regeneration and disease modeling.
Conclusion
GO:0051146 (striated muscle cell differentiation) is a central developmental process that integrates transcription-factor cascades, chromatin state, signaling pathways and extracellular matrix cues to produce contractile muscle cells. Its experimental tractability, from primary myoblasts to human pluripotent stem cell-derived fibers, makes it a powerful system for mechanistic and translational studies. Dysregulation of this process is linked to chronic kidney disease-associated muscle dysfunction, muscle wasting and structural muscle disorders, underscoring its clinical relevance. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with library screening and bioinformatics, provide a rigorous path to identify and validate the regulators that control striated muscle cell differentiation.
References
- 1. Wang W et al.. 2025. RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway.. Theranostics 15(10):4446-4464 PMID: 40225576
- 2. Bataille S et al.. 2023. Indoxyl sulfate inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation.. Nephrol Dial Transplant 39(1):103-113 PMID: 37349959
- 3. Agarwal M et al.. 2022. TLE4 regulates muscle stem cell quiescence and skeletal muscle differentiation.. J Cell Sci 135(4) PMID: 35099008
- 4. Kny M et al.. 2019. Ninjurin1 regulates striated muscle growth and differentiation.. PLoS One 14(5):e0216987 PMID: 31091274
- 5. Santarelli P et al.. 2024. Chromatin organization of muscle stem cell.. Curr Top Dev Biol 158:375-406 PMID: 38670713
- 6. Metti S et al.. 2024. Native collagen VI delays early muscle stem cell differentiation.. J Cell Sci 137(3) PMID: 38224152
- 7. Chal J et al.. 2016. Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.. Nat Protoc 11(10):1833-50 PMID: 27583644
- 8. Li P et al.. 2019. Role and mechanism of catechin in skeletal muscle cell differentiation.. J Nutr Biochem 74:108225 PMID: 31629963
